Titrzepatide reduces risk of death or worsening heart failure for patients with obesity-related heart failure

Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with heart failure, preserved heart pump function and obesity, new research from UVA Health reveals.

US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo – Biotech Investments

EQS-News: Biotest AG / Key word(s): Regulatory Admission Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo 07.09.2023 /

September 8, 2023

Football players at increased risk for Parkinson’s disease, study finds

Identification of risk factors for Parkinson’s disease (PD) is essential for early diagnosis. Dating back to the 1920s, Parkinson’s disease and parkinsonism-;an umbrella term that

August 12, 2023

URI study explores consumer perceptions and nutrition of processed foods

Ultra-processed foods make up more than half the food average Americans eat. Including frozen and prepared meals, most packaged snacks, desserts and carbonated soft drinks-;but

February 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.